Dr. Lal Pathlabs Ltd. (LALPATHLAB): Dr. Lal Pathlabs Share Price hits fresh 52-week high at Rs 1,998
- September 16, 2026
- Posted by: Harsh Piplani
- Category: News
Dr. Lal Pathlabs Share Price moved to Rs 1,998 on 16 September 2026, up 4.88% from the previous close of Rs 1,905, after touching a fresh 52-week high of Rs 2,035. The company’s market capitalisation stood at Rs 32,049.05 Cr, keeping Dr. Lal Pathlabs Share Price in focus in today’s stock news flow. The supplied data confirms the price event and the new yearly high, but it does not establish a company-specific catalyst. For readers tracking Dr. Lal Pathlabs Share Price Today, the session also included an open of Rs 1,932.25 and a low of Rs 1,932 before the stock moved to the day’s peak.
In Univest coverage, Dr. Lal Pathlabs Stock News is relevant because the stock has now marked a fresh 52-week high rather than an all-time high. Univest tracks such event-led moves alongside market capitalisation, valuation and sector context so investors can read the share price update in a structured way. Dr. Lal Pathlabs Share Price Live data for the session also shows turnover of Rs 4.69 Cr, which is a factual traded-value measure for the day.
Dr. Lal Pathlabs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,998 |
| Previous Close | Rs 1,905 |
| Today's Move | +Rs 93 (+4.88%) |
| Open | Rs 1,932.25 |
| High | Rs 2,035 |
| Low | Rs 1,932 |
| Turnover | Rs 4.69 crore |
| Market Capitalisation | Rs 32,049.05 crore |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) traded at Rs 1,998 versus the previous close of Rs 1,905, a rise of 4.88%. The stock opened at Rs 1,932.25, reached a high of Rs 2,035 and touched a low of Rs 1,932.
Dr. Lal Pathlabs Share Price Today is best read through the session numbers first. The stock opened at Rs 1,932.25, traded between Rs 1,932 and Rs 2,035, and settled at Rs 1,998 versus the previous close of Rs 1,905. That leaves a day change of Rs 93, or 4.88%, with the day high matching the fresh 52-week high of Rs 2,035. The day’s turnover was Rs 4.69 Cr, which provides a factual measure of traded value without implying any behavioural explanation. For Dr. Lal Pathlabs Share Price, the key point is simple: the stock completed a fresh one-year high session and ended above the prior close, making it a clear share price news event for the market update. In Univest terms, this is the kind of move that keeps Dr. Lal Pathlabs Share Price under active watch in Stock Market Today coverage.
The move also matters because the current price closed close to the day’s peak rather than near the low of the session. That keeps the Dr. Lal Pathlabs Share Price Today narrative anchored in the actual price path of the day, not in any inferred cause. For readers scanning Stock Updates, the stock now sits in the 52 Week High Stocks category for the session and remains a headline item in Indian Stock Market news.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 32,049.05 crore |
| P/E Ratio | 59.01x |
| P/B Ratio | 12.24x |
| ROE | 22.37% |
| ROCE | 29.56% |
| EPS | Rs 32.29 |
| Book Value Per Share | Rs 155.67 |
| Dividend Yield | 1.08% |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) fundamental metrics show P/E 59.01x, P/B 12.24x, ROE 22.37%, ROCE 29.56%. These figures provide context only and are not a buy or sell signal.
Dr. Lal Pathlabs Ltd. has a market capitalisation of Rs 32049.05 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 59.01x, P/B at 12.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.37% and ROCE of 29.56%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 32.29, book value per share of Rs 155.67, dividend yield of 1.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 46.68x, median ROE of 13.07%, median ROCE of 15.86%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 59.01x |
| Benchmark Median P/E | 46.68x |
| Benchmark Average P/E | 100.07x |
| Benchmark P/E Range | 7.05x to 1,538.24x |
| Company P/B Ratio | 12.24x |
| Benchmark Median P/B | 3.94x |
| Company ROE | 22.37% |
| Benchmark Median ROE | 13.07% |
| Company ROCE | 29.56% |
| Benchmark Median ROCE | 15.86% |
| Company Market Capitalisation | Rs 32,049.05 crore |
| Benchmark Median Market Cap | Rs 499.27 crore |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 59.01x, which is above the benchmark median of 46.68x, a difference of +26.41%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROE of 22.37%, which is above the benchmark median of 13.07%, a difference of +71.16%. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROCE of 29.56%, which is above the benchmark median of 15.86%, a difference of +86.38%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Krishna Institute of Medical Sciences Ltd | KIMS | 32,292.2 | 157.63 | 8.51 | 11.04 | 11.51 |
| Narayana Hrudayalaya Ltd. | NH | 38,161.31 | 47.49 | 8.17 | 19.86 | 16.2 |
| Global Health Ltd. | MEDANTA | 38,920.53 | 68.45 | 9.26 | 15.12 | 19.38 |
| DR AGARWALS HEALTH CARE L | AGARWALEYE | 16,073.23 | 107.4 | 7.7 | 8.69 | 16.14 |
| Vijaya Diagnostic Centre Ltd. | VIJAYA | 15,473.35 | 79.28 | 14.76 | 19.91 | 30.28 |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 59.01x compared with the displayed peer median of 79.28x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.37% compares with a peer median of 15.12% across the companies shown in the table. ROCE stood at 29.56% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 32,049.05 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Dr. Lal Pathlabs
- Dr. Lal Pathlabs Share Price touched a fresh 52-week high of Rs 2,035 and closed at Rs 1,998.
- The day move was Rs 93, or 4.88%, from the previous close of Rs 1,905.
- Market capitalisation stood at Rs 32,049.05 Cr on the supplied market update.
- P/E was 59.01 and P/B was 12.24, both above the same-industry median in the sector snapshot.
- ROE of 22.37% and ROCE of 29.56% were both above the same-industry median in the supplied benchmark.
About Dr. Lal Pathlabs
Dr. Lal Pathlabs Ltd. operates in Healthcare and the Hospital & Healthcare Services industry. The supplied records focus on market data, valuation, profitability and company financials rather than a broader business description. For Dr. Lal Pathlabs Share Price readers, the key verified profile elements are the listed market capitalisation, sector classification and the latest revenue and profit figures. Univest uses the company’s exact classification to keep Dr. Lal Pathlabs Stock News and Dr. Lal Pathlabs Company News aligned with the supplied facts.
Track Dr. Lal Pathlabs Share Price on Univest
Use Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Dr. Lal Pathlabs Share Price on Univest for live price updates, 52-week levels, market capitalisation, valuation ratios, sector context and company news. Univest also brings together share price snapshots, financial ratios and peer context so the stock can be followed in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Dr. Lal Pathlabs Share Price today?
Ans. Dr. Lal Pathlabs Share Price today was Rs 1,998, up 4.88% from the previous close of Rs 1,905. The stock also touched a fresh 52-week high of Rs 2,035 during the session.
Did Dr. Lal Pathlabs hit a fresh 52-week high?
Ans. Yes. Dr. Lal Pathlabs Share Price touched Rs 2,035, which is the supplied fresh 52-week high. The close at Rs 1,998 kept the stock near that session peak in today’s market update.
What was Dr. Lal Pathlabs market cap today?
Ans. Dr. Lal Pathlabs had a market capitalisation of Rs 32,049.05 Cr. That places the company well above the same-industry median in the supplied healthcare benchmark and keeps valuation context relevant.
How do Dr. Lal Pathlabs valuation ratios look?
Ans. The stock traded at a P/E of 59.01 and a P/B of 12.24. In the supplied same-industry benchmark, both ratios were above the median, which makes valuation an important part of Dr. Lal Pathlabs Share Price analysis.
What do Dr. Lal Pathlabs ROE and ROCE show?
Ans. Dr. Lal Pathlabs reported ROE of 22.37% and ROCE of 29.56%. Both measures were above the same-industry median in the benchmark, giving context to Dr. Lal Pathlabs Share Price and financial quality.
What do revenue and profit figures show for Dr. Lal Pathlabs?
Ans. Latest supplied company financials show revenue of Rs 7,977 Cr and net profit of Rs 1,695 Cr in Jun 26. Those compare with revenue of Rs 6,698 Cr and net profit of Rs 1,324 Cr in Jun 25.
